Medicare billing address
CMS Medicare provider billing file
2120 W Central AveToledo, OH 43606
CMS public data · NPI 1003208026
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Philip Wong, MD
Specialty
Credential
MD
NPI
1003208026
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Philip Wong, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2120 W Central AveCMS Doctors & Clinicians file
2120 W Central AveCMS Doctors & Clinicians file
905 N Macomb StIn the 2024 CMS provider billing file, this NPI had 640 Medicare beneficiaries and 9,704 total services. The average beneficiary age was 74, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$190,456.02
Total Medicare payment amount
$141,552.58
Medicare beneficiaries
640
Total services
9,704
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Ischemic heart disease
34%
CMS beneficiary-panel share
Chronic kidney disease
32%
CMS beneficiary-panel share
Atrial fibrillation
26%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 542 | $125.05 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 227 | $88.15 |
| Ultrasound measurement of bladder capacity after voiding | 223 | $10.47 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 217 | $16.27 |
| Automated urinalysis test | 161 | $2.20 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $178.98 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 58 | $81.45 |
| Diagnostic exam of bladder and urethra using an endoscope | 55 | $78.08 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 50 | $161.53 |
| Diagnostic exam of bladder and urethra using an endoscope | 31 | $78.81 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1003208026. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Tamsulosin Hcl | Tamsulosin Hcl | 517 | 987.7 | $8,770.98 |
| 2 | Gemtesa | Vibegron | 126 | 164 | $76,215.46 |
| 3 | Myrbetriq | Mirabegron | 116 | 144 | $63,580.05 |
| 4 | Finasteride | Finasteride | 92 | 224.5 | $852.10 |
| 5 | Solifenacin Succinate | Solifenacin Succinate | 62 | 82 | $2,250.34 |
| 6 | Cefadroxil | Cefadroxil | 53 | 53 | $263.89 |
| 7 | Tolterodine Tartrate Er | Tolterodine Tartrate | 38 | 66 | $4,257.53 |
| 8 | Trospium Chloride Er | Trospium Chloride | 38 | 50 | $4,625.42 |
| 9 | Alfuzosin Hcl Er | Alfuzosin Hcl | 30 | 66 | $461.41 |
| 10 | Estradiol | Estradiol | 27 | 45.5 | $1,881.46 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Toledo College Of Medicine
Graduation year
2015
Group/practice field
Promedica Genito-Urinary Surgeons Llc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.